Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
MetroHealth System
123
mi
from 43215
Cleveland, OH
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
MetroHealth System
123
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Female Sexual and Pelvic Health Institute
416
mi
from 43215
Philadelphia, PA
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Female Sexual and Pelvic Health Institute
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Integrity Medical Research (Urology Northwest)
2006
mi
from 43215
Mountlake Terrace, WA
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Integrity Medical Research (Urology Northwest)
2006
mi
from 43215
Mountlake Terrace, WA
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Univ of Washington
2006
mi
from 43215
Seattle, WA
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Silverado Research Inc
2055
mi
from 43215
Victoria,
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Silverado Research Inc
2055
mi
from 43215
Victoria,
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Women's Health Specialty Care
544
mi
from 43215
Farmington, CT
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Women's Health Specialty Care
544
mi
from 43215
Farmington, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Idaho Urologic Institute, P.A.
1725
mi
from 43215
Meridian, ID
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Idaho Urologic Institute, P.A.
1725
mi
from 43215
Meridian, ID
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Associated Surgeons and Physicians LLC DBA Women's Health Advantage
136
mi
from 43215
Fort Wayne, IN
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Associated Surgeons and Physicians LLC DBA Women's Health Advantage
136
mi
from 43215
Fort Wayne, IN
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Regional Urology
791
mi
from 43215
Shreveport, LA
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Regional Urology
791
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Chesapeake Urology Research Associates
344
mi
from 43215
Baltimore, MD
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Chesapeake Urology Research Associates
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Washington University
398
mi
from 43215
Saint Louis, MO
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Washington University
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Saint Louis University School of Medicine Department of Obstetrics, Gynecology, and Women's Health Division of Research
401
mi
from 43215
Saint Louis, MO
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Saint Louis University School of Medicine Department of Obstetrics, Gynecology, and Women's Health Division of Research
401
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Tri-Valley Urology Medical Group
1927
mi
from 43215
Murrieta, CA
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Tri-Valley Urology Medical Group
1927
mi
from 43215
Murrieta, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/6/2017
Cooper University Hospita/ Univeristy Urogynecology Associates
451
mi
from 43215
Voorhees, NJ
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/6/2017
Cooper University Hospita/ Univeristy Urogynecology Associates
451
mi
from 43215
Voorhees, NJ
Click here to add this to my saved trials
Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram
Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram
Status: Enrolling
Updated:  12/7/2017
Johns Hopkins Childrens Center
345
mi
from 43215
Baltimore, MD
Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram
Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram
Status: Enrolling
Updated: 12/7/2017
Johns Hopkins Childrens Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Mayo Clinic
1644
mi
from 43215
Scottsdale, AZ
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Mayo Clinic
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Colon and Rectal Medical Services
1978
mi
from 43215
Los Angeles, CA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Colon and Rectal Medical Services
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Galliano Private Practice
896
mi
from 43215
Port Charlotte, FL
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Galliano Private Practice
896
mi
from 43215
Port Charlotte, FL
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
USF Health
830
mi
from 43215
Tampa, FL
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
USF Health
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
North Pinellas Surgical Institute
817
mi
from 43215
Tarpon Springs, FL
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
North Pinellas Surgical Institute
817
mi
from 43215
Tarpon Springs, FL
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Cleveland Clinic Florida Health
971
mi
from 43215
Weston, FL
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Cleveland Clinic Florida Health
971
mi
from 43215
Weston, FL
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Emory University
435
mi
from 43215
Atlanta, GA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Georgia Regents Research Institute
452
mi
from 43215
Augusta, GA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Georgia Regents Research Institute
452
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Iowa Clinic
573
mi
from 43215
Des Moines, IA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Iowa Clinic
573
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Colon and Rectal Surgery Associates, Ltd
624
mi
from 43215
Minneapolis, MN
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Colon and Rectal Surgery Associates, Ltd
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Colon and Rectal Surgery, Inc
688
mi
from 43215
Omaha, NE
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Colon and Rectal Surgery, Inc
688
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
North Shore Long Island Jewish Health Systems
508
mi
from 43215
Huntington, NY
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
North Shore Long Island Jewish Health Systems
508
mi
from 43215
Huntington, NY
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Cleveland Clinic Foundation Digestive Disease Institute
129
mi
from 43215
Cleveland, OH
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Cleveland Clinic Foundation Digestive Disease Institute
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Colon and Rectal Research Foundation
397
mi
from 43215
Allentown, PA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Colon and Rectal Research Foundation
397
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated:  12/8/2017
University of Vermont Medical Center
591
mi
from 43215
Burlington, VT
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
Status: Enrolling
Updated: 12/8/2017
University of Vermont Medical Center
591
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
InterStim Prospective Database
InterStim Prospective Database for Outcomes Research
Status: Enrolling
Updated:  12/21/2017
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
InterStim Prospective Database
InterStim Prospective Database for Outcomes Research
Status: Enrolling
Updated: 12/21/2017
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Long Beach VA
1975
mi
from 43215
Long Beach, CA
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Long Beach VA
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
VA Greater Los Angeles Healthcare System
1982
mi
from 43215
Los Angeles, CA
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
VA Greater Los Angeles Healthcare System
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Stanford Univ Med Ctr
2101
mi
from 43215
Stanford, CA
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Stanford Univ Med Ctr
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Georgetown University Hospital
328
mi
from 43215
Washington,
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Georgetown University Hospital
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Holy Cross Hospital
970
mi
from 43215
Fort Lauderdale, FL
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Holy Cross Hospital
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Miami VA Healthcare System
996
mi
from 43215
Miami, FL
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Miami VA Healthcare System
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
University of Miami Hospital
993
mi
from 43215
Miami, FL
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
University of Miami Hospital
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Tampa General Hospital
831
mi
from 43215
Tampa, FL
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Tampa General Hospital
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Johns Hopkins Medical Center
345
mi
from 43215
Baltimore, MD
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Johns Hopkins Medical Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  12/22/2017
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 12/22/2017
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated:  12/27/2017
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated: 12/27/2017
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated:  12/27/2017
New York University Langone Medical Center
479
mi
from 43215
New York, NY
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated: 12/27/2017
New York University Langone Medical Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
Double-Blind Randomized Controlled Trial of Extended Release Oxybutynin Versus Placebo in Women Receiving Posterior Tibial Nerve Stimulation for Treatment of Urgency Urinary Incontinence
Status: Enrolling
Updated:  12/28/2017
Duke Urogynecology
354
mi
from 43215
Durham, NC
Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
Double-Blind Randomized Controlled Trial of Extended Release Oxybutynin Versus Placebo in Women Receiving Posterior Tibial Nerve Stimulation for Treatment of Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/28/2017
Duke Urogynecology
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
Double-Blind Randomized Controlled Trial of Extended Release Oxybutynin Versus Placebo in Women Receiving Posterior Tibial Nerve Stimulation for Treatment of Urgency Urinary Incontinence
Status: Enrolling
Updated:  12/28/2017
Duke OB/GYN Consultants of Raleigh
372
mi
from 43215
Raleigh, NC
Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
Double-Blind Randomized Controlled Trial of Extended Release Oxybutynin Versus Placebo in Women Receiving Posterior Tibial Nerve Stimulation for Treatment of Urgency Urinary Incontinence
Status: Enrolling
Updated: 12/28/2017
Duke OB/GYN Consultants of Raleigh
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials